The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer | Radiation Oncology | Full Text

The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer | Radiation Oncology | Full Text

The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer

Treatment for local and locoregional recurrence or second head-and-neck (H&N) cancers after previous radiotherapy is challenging, and re-irradiation carries a significantly increased risk for radiotherapy-rela...

Authors:Alexander Rühle, Tanja Sprave, Tobias Kalckreuth, Raluca Stoian, Erik Haehl, Constantinos Zamboglou, Roland Laszig, Andreas Knopf, Anca-Ligia Grosu and Nils H. Nicolay

Citation:Radiation Oncology 2020 15:81

Content type:Research

Published on: 16 April 2020

• ViewFull Text
 
• ViewPDF